2024
Autism Spectrum Disorder (ASD)
Rutten M, Zhong J, Rolison M, Sukhodolsky D. Autism Spectrum Disorder (ASD). 2024 DOI: 10.1016/b978-0-323-95702-1.00076-2.ChaptersAutism spectrum disorderSeverity of core symptomsIdentity-first languagePerson-first languageCore symptomsPsychiatric disordersRestricted interestsIntellectual disabilityRepetitive behaviorsSpectrum disorderSensory sensitivityNeurodevelopmental disordersSocial communicationAutismEnvironmental risk factorsAutism communityPharmacological interventionsDisordersAdvanced parental ageParental ageADHDAnxietyLanguagePhenotypic presentationDisability
2021
Brief Report: Preliminary Evidence of the N170 as a Biomarker of Response to Treatment in Autism Spectrum Disorder
Kala S, Rolison MJ, Trevisan DA, Naples AJ, Pelphrey K, Ventola P, McPartland JC. Brief Report: Preliminary Evidence of the N170 as a Biomarker of Response to Treatment in Autism Spectrum Disorder. Frontiers In Psychiatry 2021, 12: 709382. PMID: 34267691, PMCID: PMC8275957, DOI: 10.3389/fpsyt.2021.709382.Peer-Reviewed Original ResearchAutism spectrum disorderN170 latencyBehavioral treatmentSpectrum disorderFace-sensitive event-related potentialsComputer-generated facesEvent-related potentialsWaitlist control conditionASD displayFearful affectNeural processingN170Waitlist controlSubset of participantsPRT interventionElectroencephalography (EEG) dataNeurodevelopmental disordersAged childrenPreliminary evidenceObjective indexSocial functionLarge sampleExploratory studyParticipantsTreatment response
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply